Andre Levchenko is the John C. Malone Professor of Biomedical Engineering at Yale University, with secondary appointments in the Department of Neurosurgery and affiliations with the Cancer Signaling Networks, Immunology, and the Yale Program in Neurodevelopment and Regeneration. His research focuses on systems biology, signal transduction, and cell-cell communication, utilizing microfluidics and computational modeling to study cancer progression, stem cell behavior, and neurological disorders. PhD, Columbia University MEng, Moscow Institute of Physics and Technology Levchenko's work explores how cells process dynamic signals to make critical decisions, particularly in glioblastoma migration, organoid development, and cardiovascular tissue engineering. His lab develops innovative microfluidic platforms and mathematical models to dissect multicellular communication and signaling networks. Recent publications highlight his contributions to understanding YAP-driven cancer invasion , NOTCH signaling in angiogenesis , and metabolic regulation of hypoxia responses . He has pioneered methods for organoid modeling and single-cell analysis , advancing precision in biological signaling studies. Scientific Awards : Computational Molecular Biology Post-Doctoral Fellowship (Burroughs Wellcome Fund) National Academies Keck Futures Conference Invitee Distinguished Guest Lecturer, University of Virginia American Asthma Foundation Early Excellence Award Fellow, American Institute for Medical and Biological Engineering Levchenko leads the Levchenko Lab at the Yale Systems Biology Institute, collaborating with institutions like Mayo Clinic and Yale Cancer Center. His research has received recognition in Faculty of 1000 and multiple journal highlights.
Dr. Birgit Frauscher is the Lincoln Financial Group Distinguished Professor in Neurobiology at Duke University School of Medicine, where she serves as Professor of Neurology and holds a secondary appointment in the Department of Biomedical Engineering at the Duke Pratt School of Engineering. She is currently the Director of the Duke Comprehensive Epilepsy Center and leads the Analytical Neurophysiology (ANPHY) Lab. Her clinical and research work focuses on epilepsy and sleep medicine, utilizing both invasive and non-invasive electrical recordings to study brain activity in humans. Dr. Frauscher completed her medical training, neurology residency, and subspecialty training in electroencephalography, epilepsy, and sleep medicine at the Medical University of Innsbruck in Austria. After completing her clinical training in 2008, she earned her habilitation degree in 2011. She further specialized in intracranial EEG and signal analysis during a visiting professorship at the Montreal Neurological Institute and Hospital, McGill University (2013-2015), where she later served as an Attending Epileptologist and Group Leader of Epilepsy. Her research interests focus on developing novel seizure-independent EEG markers for the epileptogenic zone, investigating sleep-epilepsy interactions, and using intracranial EEG to study brain physiology during wakefulness and sleep. Her work aims to improve epilepsy diagnosis, prognosis, and treatment outcomes by better localizing the epileptic focus. Dr. Frauscher's recent publications demonstrate her continued leadership in epilepsy research, with over 170 peer-reviewed papers and an H-index of 62. Dr. Frauscher has received several prestigious awards including the Clinician-Scientist awards of the FRSQ (2018-2023), the Michael Prize of the International League against Epilepsy (2019), and the Ernst Niedermeyer Prize from the Austrian Epilepsy Society (2015). Her scholarly work has significantly advanced clinical knowledge in epilepsy and sleep medicine, establishing her as a leading figure in the field. As Director of the Duke Comprehensive Epilepsy Center and head of the ANPHY lab, Dr. Frauscher oversees a research program dedicated to advancing neuroscience through innovative approaches to studying brain activity. Her lab employs quantifiable tools to investigate neurophysiological and pathological processes related to epilepsy and sleep, with the ultimate goal of improving patient outcomes through better understanding of brain function.
Zion Zibly, MD, MBA is an Associate Professor in the Department of Neurosurgery at Yale School of Medicine . He holds multiple leadership roles including Director of the Center of Neuromodulation , Director of the Center of Neurosurgical Cancer Pain , and Head of Stereotactic & Functional Neurosurgery and the Focused Ultrasound Institute . Previously served as Chair of Neurosurgery at Sheba Medical Center after graduating from Technion’s Faculty of Medicine (MD) and Coller School of Management (MBA). Research Interests: Specializes in Neuromodulation for movement disorders (Parkinson’s, tremors, dystonia), Deep Brain Stimulation , Gene Therapy for pediatric neurodegenerative conditions, Oncological Neurosurgery , and Neurological Pain Management . Combines Functional Neurosurgery with Focused Ultrasound technology. Scientific Contributions: Participated in pioneering Alzheimer’s brain stimulator procedures and Gene Therapy applications. Active member of the North American Association of Functional Neurosurgery and Israeli Neurosurgical Society . Clinical Expertise: Implantation of electrostimulators for Parkinson’s and essential tremor, treatment of Benign/Malignant CNS Tumors , and management of Neurological Pain Conditions . Affiliated with Yale Cancer Center and Center for Brain & Mind Health .
Suradip Das is a Research Assistant Professor in the Department of Neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where he serves as a Senior Research Investigator. His work bridges neural engineering and regenerative medicine to address critical challenges in nerve and muscle repair. His academic training includes: B.Tech in Biotechnology from Heritage Institute of Technology (2010) PhD in Biosciences and Bioengineering from Indian Institute of Technology Guwahati (2016) Dr. Das specializes in biomaterials development , peripheral nerve injury models , neuromuscular interface engineering , and stem cell-based regeneration . His research pioneers innervated tissue-engineered muscle constructs, demonstrating how motor neurons and endothelial cells synergistically enhance skeletal myocyte maturation. He innovates custom mechanobioreactors that apply tensile forces to guide nanofiber alignment for optimal myofiber formation, significantly advancing volumetric muscle loss treatments. Analysis of his 15 most recent publications reveals a dominant focus on neuromuscular regeneration (75% of articles), with emerging exploration of psychedelic compounds in neural repair. His work consistently integrates human iPSC-derived models , multi-cellular co-cultures , and large-animal validation to address translational gaps. Key trends include optogenetic control of motor units (2023), porcine nerve injury models (2020), and the critical role of pre-innervation in creating pro-regenerative microenvironments (2020-2022). As a core member of the Cullen Lab, Dr. Das collaborates on developing biofabricated neural microtissues for delayed nerve fusion and rapid functional recovery. His research directly informs clinical strategies for peripheral nerve repair and muscle regeneration through rigorous mechanistic studies and innovative engineering solutions.
Maria T. Schultheis is a Professor in Drexel University's Department of Psychological and Brain Sciences and holds a joint appointment in the School of Biomedical Engineering, Science and Health Systems. As Interim Director of Clinical Training, she oversees clinical psychology education. She earned her PhD in Clinical Psychology from Drexel University in 1998. Her research focuses on neurorehabilitation, particularly applying virtual reality (VR) technology to assess and improve driving capacity and everyday functioning in individuals with neurological disorders like traumatic brain injury, stroke, and multiple sclerosis. She has pioneered VR-based driving simulators for clinical evaluation and rehabilitation. Her work integrates clinical psychology, engineering, and transportation science, addressing cognitive, physical, and behavioral demands of driving post-neurological injury. Key projects include developing driving assessment protocols for disabled populations and investigating fatigue management in MS patients. Her interdisciplinary approach has been funded by NIH, NIDRR, and the NMSS. Notable awards include the 2007 APA Early Career Award (Division 40) and recognition from the National Academy of Neuropsychology. Schultheis leads the Applied Neuro-Technologies Lab, emphasizing ecologically valid methodologies. Over 35 peer-reviewed publications and presentations at international forums highlight her contributions. She serves on the National Research Council’s Transportation Research Board, influencing policy on neurological disorders and mobility. Grants have supported projects like VR-based financial competency assessments and understanding dual-task demands in post-concussion driving. Her research also explores decision-making competency in young adults and the neurocognitive correlates of risky driving behaviors. Collaborations with biomedical engineers and transportation specialists reflect her commitment to bridging clinical practice and technological innovation for functional recovery.
Scott Michael Lindhorst, MD, is an Assistant Professor in the Department of Neurosurgery at the Medical University of South Carolina (MUSC) College of Medicine. He holds a dual appointment in the Division of Hematology/Medical Oncology within the Department of Medicine. Dr. Lindhorst specializes in neuro-oncology, focusing on central nervous system lymphomas, gliomas, and meningiomas, while also managing brain metastases through clinical trials. Education: BS in Microbiology from University of Florida (2001), MD from University of South Alabama College of Medicine (2005) Training: Residency in Internal Medicine, Fellowship in Hematology/Medical Oncology (University of Alabama at Birmingham), Fellowship in Neuro-Oncology (Duke University Medical Center) His research centers on immuno-oncology , glioblastoma therapy , and epigenetic cancer treatments , with a strong emphasis on clinical trials for novel therapies. Recent publications explore hypermutation in cancer , immune checkpoint inhibition , and programmed necrosis in glioblastoma . Dr. Lindhorst is board-certified in internal medicine, hematology, medical oncology, and neuro-oncology. Clinical practice includes CNS lymphomas , gliomas , meningiomas , and brain metastases , with dedicated clinical trials to advance treatment options.
Patrick J. Cahill, MD, is a pediatric spine specialist and the Robert M. Campbell Jr. Endowed Chair in Thoracic Insufficiency Syndrome at Children's Hospital of Philadelphia (CHOP). His clinical expertise spans disorders of the pediatric spine, scoliosis, cervical spine conditions, and minimally invasive surgical techniques. He leads the Center for Thoracic Insufficiency Syndrome, collaborating with pulmonology, anesthesia, and physical therapy teams. Academic Role: Physician Scientist Leadership: Director of the Center for Thoracic Insufficiency Syndrome Research Focus: Spinal growth modulation, 3D surgical planning, and reducing anesthesia exposure in young patients His work emphasizes fusionless treatments like magnetically expandable growing rods and Mehta casting, alongside innovations in dynamic MRI for preoperative assessment. Recent publications highlight comparative studies on spinal fusion techniques, surgical complication classifications, and multidisciplinary approaches to complex cases. Awards: Philadelphia Magazine's Top Doctors (2022), SRS Travelling Fellowship (2015) Professional Memberships: Scoliosis Research Society, North American Spine Society, Pediatric Orthopaedic Society of North America
Matthew B Potts, MD is an Associate Professor in the Department of Neurological Surgery at Northwestern University's Feinberg School of Medicine, with secondary appointments in Neurology (Ken and Ruth Davee Department) and Radiology. His clinical expertise spans cerebrovascular surgery, neurointerventional/endovascular procedures, and management of brain aneurysms, vascular malformations, stroke, and spinal vascular disease across multiple Northwestern Medicine hospitals including Shirley Ryan AbilityLab. Dr. Potts completed his BS at MIT (2000) and MD at UCSF (2007), followed by surgical internship (2008), neurological surgery residency (2013), and cerebrovascular fellowship at NYU (2015). BS: Massachusetts Institute of Technology (2000) MD: University of California, San Francisco (2007) Internship: University of California-San Francisco Medical Center, Surgery (2008) Residency: University of California-San Francisco Medical Center, Neurological Surgery (2013) Fellowship: New York University Medical Center, Endovascular/Cerebrovascular Surgery (2015) His research program centers on chronic subdural hematoma pathophysiology, emergency stroke thrombectomy process optimization, and aneurysm treatment outcomes. He employs clinical-translational approaches to improve cerebrovascular disease management through advanced surgical techniques and rigorous outcomes assessment. Recent 2025 publications reveal strong focus on hydrocephalus diagnostics, hematoma expansion biomarkers, vertebrobasilar anatomy, and dolichoectatic aneurysm natural history. These works demonstrate multidisciplinary collaboration across neurosurgery, neurology, and radiology to advance diagnostic precision and treatment efficacy in complex cerebrovascular disorders. Dr. Potts has received exceptional recognition for medical education, including three consecutive Outstanding Teacher Awards (2019-2021) and the John X. Thomas, Jr. Best Teachers Award (2020). His research contributions are honored by the NIH Rush L. Kirschstein Award (2012) and Howard Hughes Fellowship (2005). Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2021) Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2020) John X. Thomas, Jr. Best Teachers of Feinberg Award, Northwestern University Feinberg School of Medicine (2020) Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2019) Ivan Ciric Resident Teaching Award, Northwestern University Department of Neurological Surgery (2017) Best Scientific Presentation, UCSF Department of Neurological Surgery (2013) NIH Rush L. Kirschstein National Research Service Award, National Institutes of Health (2012) UCSF School of Medicine Alumni Scholarship Award, University of California, San Francisco (2006) Howard Hughes Medical Institute Medical Student Research Fellow, Howard Hughes Medical Institute (2005) UCSF Quarterly Research Fellowship, University of California, San Francisco (2005) MIT-Germany Program Research Fellowship, Massachusetts Institute of Technology (2001) As an educator, Dr. Potts mentors medical students and residents through Feinberg's neurological surgery program, evidenced by his resident teaching award. His research is supported by institutional resources and prior NIH funding, with current industry relationships including ownership in Rhaeos, Inc. He serves as Assistant Editor for Neurosurgery and Associate Editor for Operative Neurosurgery. He operates within Northwestern's integrated neurovascular team across multiple hospital sites, collaborating with neurologists, neuroradiologists, and rehabilitation specialists to deliver comprehensive care for complex cerebrovascular conditions, with ongoing work focused on improving health equity in stroke treatment and minimally invasive surgical innovation.
Frank E. Garcea, Ph.D., is a Research Assistant Professor in the Department of Neurosurgery and Neuroscience at the University of Rochester School of Medicine and Dentistry. His research focuses on the cognitive and neural mechanisms underlying tool use, apraxia, and stroke recovery. He employs neuropsychological testing, fMRI, and lesion-symptom mapping to study brain injury effects on functional connectivity and action knowledge. Education: Bachelor of Science in Psychology, St. John Fisher College (2006–2010) PhD in Brain and Cognitive Sciences, University of Rochester (2012–2017) Research Interests: Dr. Garcea investigates how brain regions like the parietal cortex and dorsal/ventral streams mediate object manipulation and tool use. His work explores stroke-related disconnection syndromes, motor speech coordination networks, and translational brain mapping to preserve neural function during surgery. He collaborates on projects involving epilepsy patients undergoing electrocorticography to study action-related neural pathways. Labs & Affiliations: Principal Investigator of the Garcea Lab at URMC, focusing on tool use deficits in brain tumor/stroke survivors. Affiliated with the Del Monte Institute for Neuroscience and the Neurobiology & Anatomy Program. His lab integrates neuroimaging, lesion analysis, and clinical care to advance personalized brain mapping strategies.
Russell S. Witte, PhD, is a Professor at the University of Arizona, jointly appointed in the departments of Medical Imaging, Optical Sciences, Biomedical Engineering, Surgery, and Neurosurgery. He is also a Professor at the BIO5 Institute and leads the Experimental Ultrasound & Neural Imaging Lab (EUNIL). His interdisciplinary work bridges physics, engineering, and medicine to develop innovative imaging technologies for diagnosing and treating neurological, cardiac, and oncological conditions. Education: PhD, Arizona State University, 2002 MS, Arizona State University, 2000 BS (Honors), Physics, University of Arizona, 1993 Dr. Witte's research centers on hybrid imaging modalities that combine ultrasound with light, microwaves, and electrical signals. His lab pioneers techniques such as photoacoustic imaging, acoustoelectric imaging, and elasticity mapping to visualize tissue function and mechanics deep within the body. These methods have transformative potential in functional brain imaging, cardiac electrophysiology, and early cancer detection. He is particularly interested in leveraging nanotechnology and smart contrast agents to enhance imaging specificity and therapeutic efficacy. His research program reflects a strong trend toward multimodal, physics-driven biomedical imaging, with applications spanning neuroscience, cardiology, and oncology. By integrating principles from biomedical engineering, optics, and applied mathematics, his work aims to bridge the gap between fundamental science and clinical translation. Scientific Affiliations and Memberships: Arizona Cancer Center Sarver Heart Center School of Mind, Brain, and Behavior Neuroscience Graduate Interdisciplinary Program Applied Mathematics Graduate Interdisciplinary Program Biomedical Engineering Graduate Interdisciplinary Program Dr. Witte is deeply committed to training the next generation of interdisciplinary scientists. He actively mentors students and encourages collaboration across engineering, medicine, and industry. His lab fosters a creative environment for dreamers, problem solvers, and innovators aiming to make transformative discoveries at the intersection of physics and medicine. He has established strong collaborative networks across the Colleges of Engineering, Optical Sciences, and Medicine, facilitating translational research with real-world clinical impact. Dr. Witte leads the Experimental Ultrasound & Neural Imaging Lab (EUNIL), a multidisciplinary research team dedicated to developing and refining cutting-edge imaging technologies. The lab focuses on translating novel physical principles into practical tools for disease diagnosis and treatment monitoring, particularly in chronic tendon disorders, arrhythmias, and breast cancer.
Mihir Gupta, MD, is an Assistant Professor of Neurosurgery at Yale School of Medicine. As a fellowship-trained spine surgeon with dual expertise in neurosurgery and orthopedics, he performs both traditional and minimally invasive procedures for complex spinal disorders including degenerative conditions, deformities, tumors, infections, and trauma-related issues. Dr. Gupta also specializes in revision spine surgeries for patients with persistent or new problems following previous operations. Dr. Gupta's educational background includes a BA from Harvard College, an MD from Stanford University School of Medicine, neurosurgical residency at the University of California San Diego, postdoctoral studies at Harvard Medical School, and an orthopedic spine surgery fellowship at Johns Hopkins University. His clinical philosophy emphasizes understanding each patient's unique story through thorough evaluation and physical examination before developing personalized treatment plans. His research interests focus on understanding how genetics contribute to different spinal disorders and how care can be personalized. Dr. Gupta's publications demonstrate expertise across multiple domains including brain tumor diagnostics (particularly CNS lymphoma and glioblastoma), spine surgery outcomes, gender diversity in academic medicine, and neuroimmunology. His work often bridges clinical practice with molecular diagnostics, emphasizing rapid testing methods that accelerate treatment decisions for brain tumor patients. Dr. Gupta collaborates extensively with multidisciplinary teams including physical therapists, pain management specialists, anesthesiologists, and interventional radiologists to develop comprehensive treatment approaches. He emphasizes that surgery is often the last resort, prioritizing nonsurgical options when appropriate. His clinical work at Yale Medicine focuses on highly personalized spine procedures using advanced robotics, navigation, and minimally invasive techniques to tailor solutions for individual patients.
University of North Carolina at Chapel HillUnited States
Gianmarco Pinton is an Associate Professor in the Department of Biomedical Engineering at the University of North Carolina at Chapel Hill. His research focuses on nonlinear ultrasound and mechanical wave propagation, with applications to medical imaging and therapy. He specializes in traumatic brain injury, shear shock waves, and ultrasound therapy. Ph.D., M.S., and B.S.E. in Biomedical Engineering/Physics from Duke University His lab develops physics and simulation tools for nonlinear wave propagation, aiming to create advanced diagnostic ultrasound methods. Key areas include traumatic brain injury, transcranial imaging, and therapeutic ultrasound. His recent work explores super-resolution imaging, brain motor circuits, and Alzheimer's disease vascular mapping using ultrasound. Article trends highlight innovations in transcranial ultrasound, super-resolution techniques, lung imaging, and neuromodulation. His publications address image degradation, contrast agents, and shear wave dynamics in neurological contexts.
University of California, Los AngelesUnited States
Martin M. Monti is a Professor of Psychology, Neurosurgery, and Psychiatry and Biobehavioral Sciences at the University of California Los Angeles (UCLA), affiliated with the College of Letters and Science. His research focuses on disorders of consciousness, traumatic brain injury (TBI), neuroimaging, and cognitive neuroscience. He holds an MA and PhD in Psychology & Neuroscience from Princeton University (2006–2007) and a BA in Economics from Università Commerciale L. Bocconi (2002). Key research interests include understanding consciousness recovery mechanisms, neuroimaging techniques for TBI assessment, and neuromodulation therapies. Recent work explores subcortical correlates of sleep quality, AI-driven models of consciousness, and transcranial focused ultrasound applications. Monti has received prestigious awards, including the UCLA Life Science Faculty Award (2020, 2014) and the International Prize Giuseppe Sciacca for Medical Research (2018). He leads interdisciplinary projects through collaborations like the ENIGMA working group and the Curing Coma Campaign, advancing global neuroimaging standards and translational research.
Aline Herlopian, MD, is an Associate Professor of Neurology at Yale School of Medicine, specializing in epilepsy and treatment-resistant seizures. She serves as Medical Director of the Clinical Neurophysiology/EEG Lab and Director of Clinical Trials in Epilepsy. Her clinical focus includes catastrophic epilepsies and innovative treatments like brain stimulation, laser therapy, and surgical resection. Clinical Epilepsy Fellowship, Massachusetts General Hospital (2017) Clinical Neurophysiology Fellowship, Massachusetts General Hospital (2016) Neurology Residency, University of Arkansas for Medical Sciences (2015) MD, American University of Beirut (2008) Her research explores neural network dynamics in epilepsy, EEG pattern classification via machine learning, and global health applications in neurological care. She has authored 15+ publications in 2024-2025, including peer-reviewed articles and book chapters on epilepsy subtypes and surgical approaches. Inaugural Global Health Education Innovation Award (2025) Dr. Herlopian leads clinical trials in epilepsy and collaborates extensively with Yale Institute for Global Health. She is a renowned advisor for patient education, emphasizing seizure demystification through analogies, and contributes to Yale Co-Authors networks in neurology research.
University of Massachusetts Chan Medical SchoolUnited States
Christine Eckhardt is an Assistant Professor in the Department of Neurology at the T.H. Chan School of Medicine (UMass Chan Medical School), specializing in Neurocritical Care. She earned her MD from Harvard Medical School and holds an MS degree. Education: MD, Harvard Medical School, Boston, MA MS (unspecified field) Dr. Eckhardt's research focuses on neurocritical care, neurotoxicity syndromes, and EEG-based diagnostics. She develops quantitative EEG methods for assessing immune effector cell-associated neurotoxicity (ICANS) and delirium severity, with applications in CAR T-cell therapy and critical care neurology. Her recent publications (2022–2023) emphasize automated neurotoxicity detection , EEG signal processing , and health equity disparities in heart failure care. Key subfields include neurocritical care, computational neuroscience, and clinical outcome modeling.